Although no official decision has yet been made on vaccinating (groups of) children between the ages of five and eleven, the first delivery of the corona vaccine from Pfizer/BioNTech for children is expected at the end of next month.

This concerns 42,000 doses with an adjusted child dose, writes caretaker minister Hugo de Jonge (Public Health) to the House of Representatives on Friday evening.

Follow this topic Follow

Receive a notification for news about corona vaccines

The Health Council expects to issue a recommendation at the end of next week on vaccinating children who belong to a medical risk group.

Then De Jonge makes a decision.

In anticipation of this, RIVM is already working on scenarios for the vaccination of children.

Earlier this week, the European Medicines Agency (EMA) ruled that the Pfizer/BioNTech vaccine is safe and effective for children aged five years or older.

The vaccine was previously approved for use by anyone aged 12 years or older.

Furthermore, through the joint purchasing procedure of the European Commission, De Jonge has placed a reservation for the anti-COVID-19 pills Paxlovid from Pfizer and Lagevrio from MSD.

According to the manufacturers, these pills prevent people who have tested positive for the corona virus from eventually becoming seriously ill.

The EMA still has to approve the medicines.


This is how the Pfizer and Moderna vaccines work in your body